CO-MOUNT-ELBERT-CAPITAL
Mount Elbert Capital Partners (“Mount Elbert”), a real-assets private equity firm with specialized capabilities in internet infrastructure, today announced that it has completed the final closing of its first fund, Mount Elbert Capital Partners Fund 1 (”Fund 1”). The Fund closed on equity commitments totaling $382 million, surpassing the initial target of $290 million. In raising Fund 1, Mount Elbert attracted a range of global investors, including pension funds, endowments, and family offices.
Fund 1 was 22% invested at December 31, 2018, investing alongside global institutional investors GIC and OPTrust in EdgeCore Internet Real Estate (“EdgeCore”). EdgeCore is an investment vehicle developing, acquiring, and operating data centers and related infrastructure, and has been initially capitalized with over $900 million of equity targeted to support approximately $2.0 billion in data center development. In addition to Mount Elbert’s investment through Fund 1, Mount Elbert affiliates serve as General Partner of and provide asset-management, development, and leasing services to EdgeCore.
“We appreciate the support of our investors and the trust they place in us. We are pleased to have been oversubscribed in Fund 1, and we believe the investment environment for the Fund is attractive,” said Tom Ray, Chairman, and CEO of Mount Elbert. “We are also pleased to have established the operating capabilities inherent in Mount Elbert’s service affiliates; we view these capabilities as invaluable and have positioned them to scale and support further investment. Experienced as both investors and operators, we work to leverage our industry relationships, investment vision, and operational insight and resources to discern a deeper layer of opportunities and risks in an investing environment featuring an abundance of both. We remain focused upon generating attractive risk-adjusted returns by sourcing attractive investment opportunities and catalyzing elevated execution through our highly driven operational capability and ethos.”
Jefferies LLC served as exclusive global placement agent and financial advisor for Mount Elbert.
This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities.
About Mount Elbert
Mount Elbert Capital Partners is a real-assets private equity firm with specialized capabilities in internet infrastructure, including data centers, colocation and interconnection assets and operating companies, and related assets. Our founders and investment professionals have experience evaluating, making and managing investments in real assets with an aggregate value exceeding $20 billion across the US, Europe, and Asia, with more than $15.0 billion in internet infrastructure. For more information, visit www.mountelbert.com .
About EdgeCore Internet Real Estate
EdgeCore Internet Real Estate is a preeminent U.S. developer, owner and operator of highly scalable, cloud-connected, wholesale data center campuses, providing solutions to the Global 2000, including hyperscale cloud and internet companies. EdgeCore is currently developing data center campuses in Dallas, Phoenix, Northern Virginia, Reno, and Silicon Valley with plans to develop campuses in additional markets. Each of the Company’s five initial campuses is designed to support between 80 and 225 MW of critical load, representing total capacity exceeding 800 MW across the Company’s current platform. EdgeCore is committed to enabling the growth and supporting the rigorous performance requirements of its customers leveraging ready-for-service capacity and bespoke build-to-suit solutions across the U.S. For more information, visit www.edgecore.com or follow us on Twitter or LinkedIn .
About GIC
GIC is a leading global investment firm with well over US$100 billion in assets under management. Established in 1981 to secure the financial future of Singapore, the firm manages Singapore’s foreign reserves. A disciplined long-term value investor, GIC is uniquely positioned for investments across a wide range of asset classes, including real estate, private equity, equities and fixed income. GIC has investments in over 40 countries and has been investing in emerging markets for more than two decades. Headquartered in Singapore, GIC employs close to 1,500 people across 10 offices in key financial cities worldwide. For more information about GIC, please visit www.gic.com.sg .
About OPTrust
A fully funded plan with net assets of over $20 billion, OPTrust invests and manages one of Canada’s largest pension funds and administers the OPSEU Pension Plan, a defined benefit plan with over 92,000 members and retirees.
OPTrust is a global investor in a broad range of asset classes including Canadian and foreign equities, fixed income, real estate, infrastructure and private markets, and has a team of highly experienced investment professionals located in Toronto, London and Sydney. As a pension management organization, OPTrust’s mission is to pay pensions today, preserve pensions for tomorrow. For more information, please visit www.optrust.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190326005303/en/
Contact:
Mount Elbert Capital Partners Claire Rowberry claire@clearcommsc.com +1 617 785 5571
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom